8-KThe WireRoutine
Company Update
Filed Feb 22, 2021 · 5y ago · Accession 0000950142-21-000731
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
February 19, 2021
SPECTRUM BRANDS HOLDINGS, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware
001-4219
74-1339132
(State or other jurisdiction of incorporation)
(Commission
File No.)
(I.R.S. Employer
Identification No.)
SB/RH HOLDINGS, LLC
(Exact Name of Registrant as Specified in its Charter)
Delaware
333-192634-03
27-2812840
(State or other jurisdiction of incorporation)
(Commission
File No.)
(I.R.S. Employer
Identification No.)
3001 Deming Way
Middleton , Wisconsin 53562
(Address of principal executive offices)
(608) 275-3340
(Registrant’s telephone number, including
area code)
Not applicable
(Former Name or Former Address, if Changed
Since Last Report)
CIK
0001592706
Amendment Flag
False
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Exchange Act:
Registrant
Title of Each Class
Trading Symbol
Name of Exchange on Which Registered
Spectrum Brands Holdings, Inc.
Common Stock, $0.01 par value
SPB
New York Stock Exchange
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Spectrum Brands Holdings, Inc.
☐
SB/RH Holdings, LLC
☐
If an emerging growth company, indicate by
checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Spectrum Brands Holdings, Inc.
☐
SB/RH Holdings, LLC
☐
Item 8.01. Other Events.
On
February 19, 2021, Spectrum Brands Holdings, Inc. (“Spectrum Brands”) issued a press release announcing that Spectrum
Brands, Inc. (the “Company”), a wholly owned subsidiary of SB/RH Holdings, LLC, priced its previously announced offering
of Senior Notes due 2031 (the “Notes”) in an aggregate principal amount of $500.0 million (increased from the previously
announced $400.0 million). A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The
Notes will not be registered under the Securities Act of 1933, as amended (the “Securities Act”) and may not be offered
or sold in the United States absent such registration or an exemption from the registration requirements of the Securities Act.
This report shall not constitute an offer to sell or a solicitation of an offer to buy any security and shall not constitute an
offer, solicitation or sale of any securities in any jurisdiction where such an offering or sale would be unlawful. This report
contains information about pending transactions, and there can be no assurance that these transactions will be completed.
Forward-Looking Statements
We
have made, implied or incorporated by reference certain forward-looking statements in this document. All statements, other than
statements of historical facts included or incorporated by reference in this document, without limitation, statements regarding
the offering of the Notes, statements or expectations about our new senior secured first lien term loan facility, statements or
expectations regarding our Global Productivity Improvement Program, our business strategy, future operations, financial condition,
estimated revenues, projected costs, projected synergies, prospects, plans and objectives of management, information concerning
expected actions of third parties, retention and future compensation of key personnel, our ability to meet environmental, social,
and governance goals and statements regarding the expected impact of the COVID-19 pandemic, economic, social, and political conditions
or civil unrest in the U.S. and other countries, and other statements regarding the Company's ability to meet its expectations
for its fiscal 2021 are forward-looking statements. When used in this document, the words future, anticipate, pro forma, seeks,
intend, plan, envision, estimate, believe, belief, expect, project, forecast, outlook, goal, target, could, would, will, can, should,
may and similar expressions are also intended to identify forward-looking statements, although not all forward-looking statements
contain such identifying words.
Since
these forward-looking statements are based upon our current expectations of future events and projections and are subject to a
number of risks and uncertainties, many of which are beyond our control and some of which may change rapidly, actual results or
outcomes may differ materially from those expressed or implied herein, and you should not place undue reliance on these statements.
Important factors that could cause our actual results to differ materially from those expressed or implied herein include, without
limitation: (1) the impact of the COVID-19 pandemic on our customers, employees, manufacturing facilities, suppliers, the capital
markets and our financial condition, and results of operations, all of which tend to aggravate the other risks and uncertainties
we face; (2) the impact of our indebtedness on our business, financial condition and results of operations; (3) the impact of
restrictions in our debt instruments on our ability to operate our business, finance our capital needs or pursue or expand business
strategies; (4) any failure to comply with financial covenants and other provisions and restrictions of our debt instruments;
(5) the effects of general economic conditions, including the impact of, and changes to tariffs and trade policies, inflation,
recession or fears of a recession, depression or fears of a depression, labor costs and stock market volatility or monetary or
fiscal policies in the countries where we do business; (6) the impact of fluctuations in transportation and shipment costs, in
commodity prices, costs or availability of raw materials or terms and conditions available from suppliers, including suppliers’
willingness to advance credit; (7) interest rate and exchange rate fluctuations; (8) the loss of, significant reduction in, or
dependence upon, sales to any significant retail customer(s); (9) competitive promotional activity or spending by competitors,
or price reductions by competitors; (10) the introduction of new product features or technological developments by competitors
and/or the development of new competitors or competitive brands; (11) the impact of actions taken by significant stockholders;
(12) changes in consumer spending preferences and demand for our products, particularly in light of the COVID-19 pandemic and
economic stress; (13) our ability to develop and successfully introduce new products, protect our intellectual property and avoid
infringing the intellectual property of third parties; (14) our ability to successfully identify, implement, achieve and sustain
productivity improvements (including our Global Productivity Improvement Program), cost efficiencies (including at our manufacturing
and distribution operations) and cost savings; (15) the seasonal nature of sales of certain of our products; (16) the effects
of climate change and unusual weather activity, as well as further natural disasters and pandemics; (17) the cost and effect of
unanticipated legal, tax or regulatory proceedings or new laws or regulations (including environmental, public health and consumer
protection regulations); (18) our discretion to conduct, suspend or discontinue our share repurchase program (including our discretion
to conduct purchases, if any, in a variety of manners including open-market purchases or privately negotiated transactions); (19)
public perception regarding the safety of products that we manufacture and sell, including the potential for environmental liabilities,
product liability claims, litigation
and
other claims related to products manufactured by us and third parties; (20) the impact of existing, pending or threatened litigation,
government regulations or other requirements or operating standards applicable to our business; (21) the impact of cybersecurity
breaches or our actual or perceived failure to protect company and personal data, including our failure to comply with new and
increasingly complex global data privacy regulations; (22) changes in accounting policies applicable to our business; (23) our
ability to utilize net operating loss carry-forwards to offset tax liabilities from future taxable income; (24) the impact of expenses
resulting from the implementation of new business strategies, divestitures or current and proposed restructuring activities; (25)
our ability to successfully implement further acquisitions or dispositions and the impact of any such transactions on our financial
performance; (26) the unanticipated loss of key members of senior management and the transition of new members of our management
teams to their new roles; (27) the impact of economic, social and political conditions or civil unrest in the U.S. and other countries;
(28) the effects of political or economic conditions, terrorist attacks, acts of war, natural disasters, public health concerns
or other unrest in international markets; (29) our ability to achieve our goals regarding environmental, social and governance
practices; (30) our increased reliance on third party partners, suppliers, and distributors to achieve our business objectives;
and (31) the other risk factors set forth in the securities filings of Spectrum Brands Holdings, Inc. and SB/RH Holdings, LLC,
including the 2020 Annual Report and subsequent Quarterly Reports on Form 10-Q.
Some
of the above-mentioned factors are described in further detail in the sections entitled “Risk Factors” in our annual
and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the
date hereof, or as otherwise specified, as our business, financial condition, results of operations and prospects may have changed
since such date. Except as required by applicable law, including the securities laws of the United States and the rules and regulations
of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors
or assumptions affecting such forward-looking statements.
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibits.
The following exhibits are being filed
with this Current Report on Form 8-K.
Exhibit No.
Description
99.1
Press Release dated February 19, 2021.
104
Cover Page Interactive Data File (embedded within the Inline XBRL
document)
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this report on Form 8-K to be signed on its behalf by the undersigned,
thereunto duly authorized.
SPECTRUM BRANDS HOLDINGS, INC.
By:
/s/ Ehsan Zargar
Name:
Ehsan Zargar
Title:
Executive Vice President, Corporate Secretary and General Counsel
SB/RH HOLDINGS, LLC
By:
/s/ Ehsan Zargar
Name:
Ehsan Zargar
Title:
Executive Vice President, Corporate Secretary and General Counsel
Dated: February 19, 2021
Filing details
- Ticker
- SPB
- CIK
- 109177
- Form type
- 8-K
- Filing date
- Feb 22, 2021
- Report date
- Feb 19, 2021
- Document
- eh210132777_8k.htm
- Size
- 302 KB